Galderma has announced a European re-launch of Sculptra (injectable poly-L-lactic acid)—a collagen stimulator—with an updated administration protocol. This means that the product is ready for use more quickly following reconstitution, with increased levels of comfort for patients. Sculptra can now be used immediately following a two-minute reconstitution and with the optional addition of lidocaine for patient comfort. Previously, health care professionals had to wait two hours following reconstitution to administer the product. Sculptra now has the fastest reconstitution protocol of any injectable poly-L-lactic acid (PLLA) available in Europe, representing a significant growth opportunity for Galderma.
Read more at Galderma >>